Published in Trans Am Soc Artif Intern Organs on January 01, 1981
Safe anticoagulation when heart and lungs are "on vacation". Ann Transl Med (2015) 0.79
Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation (1991) 4.89
Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA (1979) 3.69
Respiratory diseases among U.S. military personnel: countering emerging threats. Emerg Infect Dis (1999) 2.61
Effect of heparin on the activation of factor XII and the contact system in plasma. Thromb Haemost (1991) 2.29
Platelet function in hyperlipoproteinemia. N Engl J Med (1974) 2.23
Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg (1992) 2.22
Restraining infarct expansion preserves left ventricular geometry and function after acute anteroapical infarction. Circulation (1999) 2.19
Kallikrein-kinin system in inflammatory bowel diseases: Intestinal involvement and correlation with the degree of tissue inflammation. Dig Liver Dis (2005) 2.18
Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema. N Engl J Med (1983) 2.18
Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg (1996) 2.11
Striking paucity of HLA-A, B, C and beta 2-microglobulin on human neuroblastoma cell lines. J Immunol (1983) 2.08
Interaction of plasma kallikrein with the C1 inhibitor. J Immunol (1970) 2.07
Rapid detection of alpha-thalassaemia deletions and alpha-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol (2000) 1.95
Patent ducts arteriosus in premature infants. Incidence, relation to pulmonary disease and management. N Engl J Med (1972) 1.93
Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest (1975) 1.88
Disseminated intravascular coagulation (DIC): an approach. Am J Med (1972) 1.87
Large animal model of left ventricular aneurysm. Ann Thorac Surg (1989) 1.77
Dynamic three-dimensional imaging of the mitral valve and left ventricle by rapid sonomicrometry array localization. J Thorac Cardiovasc Surg (1996) 1.76
Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Proc Natl Acad Sci U S A (1976) 1.69
Changes in passive mechanical stiffness of myocardial tissue with aneurysm formation. Circulation (1994) 1.66
Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. J Lab Clin Med (1992) 1.65
Coagulation studies in the hyperacute and other forms of renal-allograft rejection. N Engl J Med (1969) 1.62
Purification and characterization of a potent 70-kDa thiol lysyl-proteinase (Lys-gingivain) from Porphyromonas gingivalis that cleaves kininogens and fibrinogen. J Biol Chem (1993) 1.61
Large animal model of ischemic mitral regurgitation. Ann Thorac Surg (1994) 1.57
Dissecting the loci controlling fetal haemoglobin production on chromosomes 11p and 6q by the regressive approach. Nat Genet (1996) 1.57
Platelet hypersensitivity induced by cholesterol incorporation. J Clin Invest (1975) 1.55
Plasma kallikrein and Hageman factor in Gram-negative bacteremia. Ann Intern Med (1970) 1.53
Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins. J Clin Invest (1969) 1.52
Guidelines for reporting morbidity and mortality after cardiac valvular operations. Eur J Cardiothorac Surg (1988) 1.50
Heparin-induced platelet activation in sixteen surgical patients: diagnosis and management. J Vasc Surg (1987) 1.49
Cytochemical reactions of human leprosy bacilli and mycobacteria: ultrastructural implications. J Bacteriol (1973) 1.46
Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma. J Clin Invest (1982) 1.45
Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. Circulation (1996) 1.45
The kallikreinogen-kallikrein enzyme system of human plasma. Assay of components and observations in disease states. Ann Intern Med (1969) 1.45
Activation of plasminogen by human plasma kallikrein. Biochem Biophys Res Commun (1969) 1.44
Carcinoma of the ampulla of Vater. Ann Surg (1987) 1.43
Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. J Clin Invest (1977) 1.42
Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations. Sri Lanka Thalassaemia Study Group. Lancet (2000) 1.42
Lack of clinically significant contact system activation during platelet concentrate filtration by leukocyte removal filters. Blood (1998) 1.42
The etiology of intestinal obstruction in patients without prior laparotomy or hernia. Am Surg (1998) 1.42
In vivo measurement of gastric mucus pH in canines: effect of high luminal acidity and prostaglandin E2. Gastroenterology (1988) 1.41
Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen. Biochemistry (1981) 1.41
Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of The American Association for Thoracic Surgery and The Society of Thoracic Surgeons. J Thorac Cardiovasc Surg (1996) 1.41
Myocardial oxygen utilization after reversible global ischemia. J Thorac Cardiovasc Surg (1990) 1.40
Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor. J Clin Invest (1984) 1.40
Invited letter concerning: aprotinin. J Thorac Cardiovasc Surg (1991) 1.40
Relationship between total mechanical energy and oxygen consumption in the stunned myocardium. Ann Thorac Surg (1990) 1.40
Off-pump extraction of an embedded high posterior left ventricular bullet utilizing a new cardiac stabilization device. J Trauma (2001) 1.39
Purified plasma factor XIIa aggregates human neutrophils and causes degranulation. Blood (1986) 1.38
The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons. J Clin Invest (1993) 1.38
Uncomfortable issues. Ann Thorac Surg (1990) 1.37
Surface-mediated defense reactions. The plasma contact activation system. J Clin Invest (1984) 1.35
Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein. J Clin Invest (1969) 1.34
More on kininogen measurements in platelet concentrates that are white cell (WBC) reduced with WBC-reduction filters. Transfusion (1996) 1.33
Management of infected thoracic aortic prosthetic grafts. Ann Thorac Surg (1984) 1.31
Interaction of malaria with a common form of severe thalassemia in an Asian population. Proc Natl Acad Sci U S A (2009) 1.29
Neutrophil elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome. Am Rev Respir Dis (1985) 1.27
Circulating anticoagulants to factor VIII. Immunochemical studies and clinical response to factor VIII concentrates. Am J Med (1970) 1.26
Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase. Biochemistry (1984) 1.25
Haemoglobin E beta thalassaemia in Sri Lanka. Lancet (2005) 1.23
Origin of the high molecular weight activator of prekallikrein. J Biol Chem (1973) 1.22
Human plasma kallikrein releases neutrophil elastase during blood coagulation. J Clin Invest (1983) 1.22
Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen. J Clin Invest (1982) 1.21
Formation of human plasma kinin. N Engl J Med (1974) 1.21
Human plasma prekallikrein: a rapid high-yield method for purification. Eur J Biochem (1979) 1.17
The regulation of human factor XIIa by plasma proteinase inhibitors. J Biol Chem (1985) 1.17
Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Arterioscler Thromb (1992) 1.16
Pathogenesis of ischemic mitral insufficiency. J Thorac Cardiovasc Surg (1993) 1.16
Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture. J Clin Invest (1975) 1.16
The low density lipoprotein receptor active conformation of apolipoprotein E. Helix organization in n-terminal domain-phospholipid disc particles. J Biol Chem (1998) 1.14
A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases. N Engl J Med (1970) 1.14
The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications. Blood Cells Mol Dis (2003) 1.14
"Shaggy" aorta syndrome with atheromatous embolization to visceral vessels. Ann Vasc Surg (1991) 1.13
Purified human plasma kallikrein aggregates human blood neutrophils. J Clin Invest (1982) 1.13
Thromboembolic complications of current cardiac valvular prostheses. Ann Thorac Surg (1982) 1.12
Pathogenesis of acute ischemic mitral regurgitation in three dimensions. J Thorac Cardiovasc Surg (1995) 1.11
Identification of adenine nucleotide binding proteins in human platelet membranes by affinity labeling with 5'-p-flurosulfonylbenzoyl adenosine. J Biol Chem (1978) 1.11
Human factor XII (Hageman factor) autoactivation by dextran sulfate. Circular dichroism, fluorescence, and ultraviolet difference spectroscopic studies. J Biol Chem (1992) 1.11
Subcellular localization and secretion of factor V from human platelets. Proc Natl Acad Sci U S A (1981) 1.09
Critical role of the carbohydrate side chains of collagen in platelet aggregation. J Clin Invest (1972) 1.09
Cyclic AMP metabolism in cholesterol-rich platelets. J Biol Chem (1977) 1.09
A primate model of hyperacute renal allograft rejection. Am J Pathol (1975) 1.09
Management of left ventricular assist device infection with heart transplantation. Ann Thorac Surg (1997) 1.08
Bar calcification of the mitral anulus. A risk factor in mitral valve operations. J Thorac Cardiovasc Surg (1987) 1.08
Surgery using cardiopulmonary bypass in the elderly. Circulation (1978) 1.08
Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation (1996) 1.08
Elimination of the acid fastness but not the gram positivity of leprosy bacilli after extraction with pyridine. J Bacteriol (1971) 1.07
Cases of thymoma at the Massachusetts General Hospital. J Thorac Cardiovasc Surg (1966) 1.07
Human neutrophils contain and bind high molecular weight kininogen. J Clin Invest (1989) 1.07
The shape of high molecular weight kininogen. Organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy. J Biol Chem (1994) 1.06
Invited letter concerning: topical aprotinin. J Thorac Cardiovasc Surg (1995) 1.06
Multicentric origin of hemochromatosis gene (HFE) mutations. Am J Hum Genet (1999) 1.06
Clinical experience with the Alvarez and Starr-Edwards prosthetic mitral valves. J Thorac Cardiovasc Surg (1966) 1.06